Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)
Abstract Background Pancreatic cancer is susceptible to gemcitabine resistance, and patients receive less benefit from gemcitabine chemotherapy. Previous studies report that gambogic acid possesses antineoplastic properties; however, to our knowledge, there have been no specific studies on its effec...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2017-08-01
|
| Seri Bilgileri: | Journal of Experimental & Clinical Cancer Research |
| Konular: | |
| Online Erişim: | http://link.springer.com/article/10.1186/s13046-017-0579-0 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|